DB
SGRY icon

Danske Bank’s Surgery Partners SGRY Stock Holding History

Danske Bank’s Portfolio SGRY Stock Details SGRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-15,805
Closed -$471K – 1246
2024
Q1 		$471K Buy
+15,805
New +$494K ﹤0.01% 887

Other funds holding SGRY

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Danske Bank's SGRY Position: Q2 2024 in Review

Danske Bank sold out of Surgery Partners (SGRY) in Q2 2024, closing a stake of 15,805 shares — an estimated $471K sold.

Danske Bank first reported a position in SGRY in Q1 2024 and held it in 1 quarter. The position peaked at $471K in Q1 2024. 179 funds tracked by Wall St. Rank hold SGRY as of Q2 2024.

  • Danske Bank reported no remaining Surgery Partners position as of Q2 2024 after selling out during the quarter.
  • Danske Bank sold 15,805 Surgery Partners shares in Q2 2024, an estimated $471K.
  • Danske Bank first reported a position in Surgery Partners in Q1 2024 and held it in 1 quarter.
  • Danske Bank's Surgery Partners position peaked at $471K in Q1 2024.
  • 179 funds tracked by Wall St. Rank held Surgery Partners as of Q2 2024.

Based on Danske Bank's 13F filing for Q2 2024, filed 18 Mar 2026.